Karyopharm Therapeutics Inc.

Q2 2023 13F Holders

Symbol
KPTI
CUSIP
48576U106
Type
Equity
Class
COM
Num filers
140
Total reported value, excl. options
$145 M
Manager Report Date Value ($000) Shares Option Type